Cargando…
Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis
Patient-derived xenograft (PDX) mouse models are increasingly used for preclinical therapeutic testing of human cancer. A limitation in molecular and genetic characterization of PDX tumors is the presence of integral murine stroma. This is particularly problematic for genomic sequencing of PDX model...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017757/ https://www.ncbi.nlm.nih.gov/pubmed/27611664 http://dx.doi.org/10.1371/journal.pone.0160587 |
_version_ | 1782452813618479104 |
---|---|
author | Schneeberger, Valentina E. Allaj, Viola Gardner, Eric E. Poirier, J. T. Rudin, Charles M. |
author_facet | Schneeberger, Valentina E. Allaj, Viola Gardner, Eric E. Poirier, J. T. Rudin, Charles M. |
author_sort | Schneeberger, Valentina E. |
collection | PubMed |
description | Patient-derived xenograft (PDX) mouse models are increasingly used for preclinical therapeutic testing of human cancer. A limitation in molecular and genetic characterization of PDX tumors is the presence of integral murine stroma. This is particularly problematic for genomic sequencing of PDX models. Rapid and dependable approaches for quantitating stromal content and purifying the malignant human component of these tumors are needed. We used a recently developed technique exploiting species-specific polymerase chain reaction (PCR) amplicon length (ssPAL) differences to define the fractional composition of murine and human DNA, which was proportional to the fractional composition of cells in a series of lung cancer PDX lines. We compared four methods of human cancer cell isolation: fluorescence-activated cell sorting (FACS), an immunomagnetic mouse cell depletion (MCD) approach, and two distinct EpCAM-based immunomagnetic positive selection methods. We further analyzed DNA extracted from the resulting enriched human cancer cells by targeted sequencing using a clinically validated multi-gene panel. Stromal content varied widely among tumors of similar histology, but appeared stable over multiple serial tumor passages of an individual model. FACS and MCD were superior to either positive selection approach, especially in cases of high stromal content, and consistently allowed high quality human-specific genomic profiling. ssPAL is a dependable approach to quantitation of murine stromal content, and MCD is a simple, efficient, and high yield approach to human cancer cell isolation for genomic analysis of PDX tumors. |
format | Online Article Text |
id | pubmed-5017757 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-50177572016-09-27 Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis Schneeberger, Valentina E. Allaj, Viola Gardner, Eric E. Poirier, J. T. Rudin, Charles M. PLoS One Research Article Patient-derived xenograft (PDX) mouse models are increasingly used for preclinical therapeutic testing of human cancer. A limitation in molecular and genetic characterization of PDX tumors is the presence of integral murine stroma. This is particularly problematic for genomic sequencing of PDX models. Rapid and dependable approaches for quantitating stromal content and purifying the malignant human component of these tumors are needed. We used a recently developed technique exploiting species-specific polymerase chain reaction (PCR) amplicon length (ssPAL) differences to define the fractional composition of murine and human DNA, which was proportional to the fractional composition of cells in a series of lung cancer PDX lines. We compared four methods of human cancer cell isolation: fluorescence-activated cell sorting (FACS), an immunomagnetic mouse cell depletion (MCD) approach, and two distinct EpCAM-based immunomagnetic positive selection methods. We further analyzed DNA extracted from the resulting enriched human cancer cells by targeted sequencing using a clinically validated multi-gene panel. Stromal content varied widely among tumors of similar histology, but appeared stable over multiple serial tumor passages of an individual model. FACS and MCD were superior to either positive selection approach, especially in cases of high stromal content, and consistently allowed high quality human-specific genomic profiling. ssPAL is a dependable approach to quantitation of murine stromal content, and MCD is a simple, efficient, and high yield approach to human cancer cell isolation for genomic analysis of PDX tumors. Public Library of Science 2016-09-09 /pmc/articles/PMC5017757/ /pubmed/27611664 http://dx.doi.org/10.1371/journal.pone.0160587 Text en © 2016 Schneeberger et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Schneeberger, Valentina E. Allaj, Viola Gardner, Eric E. Poirier, J. T. Rudin, Charles M. Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis |
title | Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis |
title_full | Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis |
title_fullStr | Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis |
title_full_unstemmed | Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis |
title_short | Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis |
title_sort | quantitation of murine stroma and selective purification of the human tumor component of patient-derived xenografts for genomic analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017757/ https://www.ncbi.nlm.nih.gov/pubmed/27611664 http://dx.doi.org/10.1371/journal.pone.0160587 |
work_keys_str_mv | AT schneebergervalentinae quantitationofmurinestromaandselectivepurificationofthehumantumorcomponentofpatientderivedxenograftsforgenomicanalysis AT allajviola quantitationofmurinestromaandselectivepurificationofthehumantumorcomponentofpatientderivedxenograftsforgenomicanalysis AT gardnererice quantitationofmurinestromaandselectivepurificationofthehumantumorcomponentofpatientderivedxenograftsforgenomicanalysis AT poirierjt quantitationofmurinestromaandselectivepurificationofthehumantumorcomponentofpatientderivedxenograftsforgenomicanalysis AT rudincharlesm quantitationofmurinestromaandselectivepurificationofthehumantumorcomponentofpatientderivedxenograftsforgenomicanalysis |